Dual GIP/GLP-1 agonist under investigation for glycemic regulation and adiposity control.
Research Summary: Dual GIP/GLP-1 agonist under investigation for glycemic regulation and adiposity control.
Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.